Global Markets Direct’s, ‘Acetylon Pharmaceuticals, Inc. – Product Pipeline Review – 2015′, provides an overview of the Acetylon Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acetylon Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• The report provides brief overview of Acetylon Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
• The report reviews current pipeline of Acetylon Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
• The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
• Special feature on out-licensed and partnered product portfolio
• The report summarizes all the dormant and discontinued pipeline projects
• Latest company statement
• Latest news and deals relating to the Acetylon Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

• Evaluate Acetylon Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
• Assess the growth potential of Acetylon Pharmaceuticals, Inc. in its therapy areas of focus
• Identify new drug targets and therapeutic classes in the Acetylon Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
• Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
• Develop strategic initiatives by understanding the focus areas of Acetylon Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Plan mergers and acquisitions effectively by identifying the most promising pipeline of Acetylon Pharmaceuticals, Inc.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
• Explore the dormant and discontinued projects of Acetylon Pharmaceuticals, Inc. and identify potential opportunities in those areas
• Avoid Intellectual Property Rights related issues

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 4
Acetylon Pharmaceuticals, Inc. Snapshot 5
Acetylon Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Acetylon Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Acetylon Pharmaceuticals, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Acetylon Pharmaceuticals, Inc. - Pipeline Products Glance 11
Acetylon Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Acetylon Pharmaceuticals, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Acetylon Pharmaceuticals, Inc. - Drug Profiles 15
ricolinostat 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
ACY-738 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
ACY-775 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ACY-957 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
Small Molecule to Inhibit HDAC for Oncology and Non Malignant Disorders 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Small Molecules to Inhibit HDAC for Malaria 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Acetylon Pharmaceuticals, Inc. - Pipeline Analysis 22
Acetylon Pharmaceuticals, Inc. - Pipeline Products by Target 22
Acetylon Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 23
Acetylon Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 24
Acetylon Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 25
Acetylon Pharmaceuticals, Inc. - Recent Pipeline Updates 26
Acetylon Pharmaceuticals, Inc. - Dormant Projects 31
Acetylon Pharmaceuticals, Inc. - Locations And Subsidiaries 32
Head Office 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 33
Disclaimer 34

List of Tables

Acetylon Pharmaceuticals, Inc., Key Information 5
Acetylon Pharmaceuticals, Inc., Key Facts 5
Acetylon Pharmaceuticals, Inc. - Pipeline by Indication, 2015 8
Acetylon Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 9
Acetylon Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 10
Acetylon Pharmaceuticals, Inc. - Phase II, 2015 11
Acetylon Pharmaceuticals, Inc. - Phase I, 2015 12
Acetylon Pharmaceuticals, Inc. - Preclinical, 2015 13
Acetylon Pharmaceuticals, Inc. - Discovery, 2015 14
Acetylon Pharmaceuticals, Inc. - Pipeline by Target, 2015 22
Acetylon Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 23
Acetylon Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 24
Acetylon Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 25
Acetylon Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 26
Acetylon Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 31

List of Figures

Acetylon Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 7
Acetylon Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 9
Acetylon Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 10
Acetylon Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 22
Acetylon Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015 23
Acetylon Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 24
Acetylon Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 25